(Q38051207)

27 August 2017

title

Impact of gastrointestinal surgery on cardiometabolic risk (English)

1 reference

27 August 2017

3

Jean-Pierre Després

1 reference

27 August 2017

4

André Tchernof

1 reference

27 August 2017

Fady Moustarah

1

1 reference

27 August 2017

Audrée Gilbert

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current Atherosclerosis Reports

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

588-596

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-012-0288-2

27 August 2017

exact match

0 references

cites work

Prevalence of class I, II and III obesity in Canada

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Annual Deaths Attributable to Obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Morbidity of severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Pain in the obese: impact on health-related quality-of-life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Quality of life in relation to overweight and body fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

The effect of age on the association between body-mass index and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Medical and surgical options in the treatment of severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Long-term weight control study: conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Duodenal switch: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

The history and evolution of bariatric surgical procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Evolution of lipid profiles after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Change in predicted 10-year cardiovascular risk following Roux-en-Y gastric bypass surgery: who benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Longitudinal analysis of cardiovascular parameters after gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Relationship between the preoperative body mass index and the resolution of metabolic syndrome following Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Weight loss reduces C-reactive protein levels in obese postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic sleeve gastrectomy in obese adolescents: results in 51 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Preliminary outcomes 1 year after laparoscopic sleeve gastrectomy based on Bariatric Analysis and Reporting Outcome System (BAROS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic sleeve gastrectomy is a safe and effective bariatric procedure for the lower BMI (35.0-43.0 kg/m2) population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Long-term follow-up after laparoscopic sleeve gastrectomy: 8-9-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Early postoperative outcomes and medication cost savings after laparoscopic sleeve gastrectomy in morbidly obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement--short-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Early results of a Canadian laparoscopic sleeve gastrectomy experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Five-year follow-up after biliopancreatic diversion with duodenal switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0288-2

Biliopancreatic Diversion with a New Type of Gastrectomy

21 January 2018

1 reference

12 December 2020

Bariatric surgery in adolescents: a long-term follow-up study

1 reference

12 December 2020

Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity

1 reference

12 December 2020

Re-sleeve gastrectomy for failed laparoscopic sleeve gastrectomy: a feasibility study

1 reference

12 December 2020

Resistin levels in morbid obese patients following the biliopancreatic diversion surgery

1 reference

12 December 2020

Inhibition of C-reactive protein in morbidly obese patients after laparoscopic sleeve gastrectomy

1 reference

12 December 2020

Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile

1 reference

12 December 2020

Medical management of obesity

1 reference

12 December 2020

Is biliopancreatic diversion with duodenal switch indicated for patients with body mass index <50 kg/m2?

1 reference

12 December 2020

Inadequacy of BMI as an indicator for bariatric surgery

1 reference

12 December 2020

Obesity, disease, and functional limitation in later life

1 reference

12 December 2020

Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity

1 reference

12 December 2020

Trace element status and inflammation parameters after 6 months of Roux-en-Y gastric bypass

1 reference

12 December 2020

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up

1 reference

12 December 2020

Duodenal switch improved standard biliopancreatic diversion: a retrospective study

1 reference

12 December 2020

Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity

1 reference

12 December 2020

Biliopancreatic diversion (doudenal switch procedure).

1 reference

12 December 2020

Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy

1 reference

12 December 2020

Twenty years of biliopancreatic diversion: what is the goal of the surgery?

1 reference

12 December 2020

Gastric bariatric operation in insulin-treated adults

1 reference

12 December 2020

Long-term cardiovascular benefits of bariatric surgery

1 reference

12 December 2020

Gastrointestinal surgery for severe obesity

1 reference

12 December 2020

Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases

1 reference

12 December 2020

10.1007/S11883-012-0288-2

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1031770331

0 references

1 reference